CXCL5 and atherosclerosis: In contrast, Cxcl5 expression increased in animals treated with Por-NPs in the aortic arch in vivo. However, CXCL5 has been shown previously to reduce foam cell formation in atherosclerosis [37], so upregulation might lead to an overall anti-atherogenic effect in vivo.